By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – BioSeek has received $696,000 in funding from the US Environmental Protection Agency to continue providing cell-based assay screening support for the EPA ToxCast screening program, the Asterand subsidiary said today.

BioSeek said that under the phase II funding it will continue to use its BioMap Systems platform, which combines human cell-based assay data with clinically relevant results, to study compounds for their potential toxicity and effects on human health.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.